Goldman Sachs is telling investors to take a breath. Peter Oppenheimer, the bank’s chief global equity strategist, has told investors today that markets aren’t crashing—just cooling. “In our view, ...
Moderna (MRNA) stock falls as Goldman Sachs downgrades the COVID-19 vaccine maker to Neutral from Buy, citing a lack of ...
In the latest quarter, 10 analysts provided ratings for Goldman Sachs Gr (NYSE:GS), showcasing a mix of bullish and bearish perspectives. The table below offers a condensed view of their recent ...
We recently compiled a list of the Top 10 AI Stocks Dominating Wall Street. In this article, we are going to take a look at ...
Goldman Sachs has initiated coverage of Vera Therapeutics (NASDAQ:VERA) with a buy rating, citing the potential of its drug candidate atacicept and a recent pullback in the stock. The investment bank ...
One stock that might be an intriguing choice for investors right now is The Goldman Sachs Group, Inc. GS. This is because this security in the Financial - Investment Bank space is seeing solid ...
Hedge funds were already waiting to see if a U.S.-fostered, home-grown artificial intelligence boom would continue as China's ...
Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.
This particularly applies to tech giants and popular consumer-facing stocks. What if you'd invested in Goldman Sachs (GS) ten years ago? It may not have been easy to hold on to GS for all that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback